down arrow

Theseus Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Biotechnology
  • ISIN: US88369M1018
USD
4.06
0.00 (0.00%)

Feb 15

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.000.00

52 Week

2.0512.31
Valuation
Technical
Day's Volume

CASH

0

Shareholding (Dec 2023)

FII

6.53%

Held by 22 FIIs

DII

17.4%

Held by 19 DIIs

Promoter

62.36%

How big is Theseus Pharmaceuticals, Inc.?

22-Jun-2025

As of Feb 15, Theseus Pharmaceuticals, Inc. has a market capitalization of 179.57 million, with net sales of 0.00 million and a net profit of -56.61 million. Shareholder's funds were 207.62 million, and total assets amounted to 222.45 million as of Dec'22.

As of Feb 15, Theseus Pharmaceuticals, Inc. has a market capitalization of 179.57 million, categorizing it as a Micro Cap company.<BR><BR>As of the latest four quarters, the company reported net sales of 0.00 million and a net profit of -56.61 million.<BR><BR>As of Dec'22, the shareholder's funds were 207.62 million, and the total assets amounted to 222.45 million.

Read More

What does Theseus Pharmaceuticals, Inc. do?

22-Jun-2025

Theseus Pharmaceuticals, Inc. is a micro-cap biotechnology company with a recent net profit loss of $14 million and a market cap of $179.57 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -25.21%.

Overview: Theseus Pharmaceuticals, Inc. operates in the biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: Most recent Net Profit: -14 Million (Quarterly Results - Sep 2023). Market cap: USD 179.57 Million (Micro Cap).<BR><BR>Key Metrics: P/E: NA (Loss Making), Industry P/E: NA, Dividend Yield: 0.00%, Debt Equity: -0.91, Return on Equity: -25.21%, Price to Book: 0.80.<BR><BR>Contact Details: Not available.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Biotechnology

stock-summary
Market cap

USD 180 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.91

stock-summary
Return on Equity

-25.21%

stock-summary
Price to Book

0.80

Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-14 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.03%
0%
23.03%
6 Months
32.9%
0%
32.9%
1 Year
-63.42%
0%
-63.42%
2 Years
-66.99%
0%
-66.99%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Theseus Pharmaceuticals, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-369.14%
EBIT to Interest (avg)
-25.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.91
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.80
EV to EBIT
0.37
EV to EBITDA
0.38
EV to Capital Employed
-1.23
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-25.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 19 Schemes (13.71%)

Foreign Institutions

Held by 22 Foreign Institutions (6.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2023 is 8.16% vs -98.65% in Sep 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-16.40",
          "val2": "-15.80",
          "chgp": "-3.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.50",
          "val2": "-14.70",
          "chgp": "8.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -85.35% vs -127.50% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-53.60",
          "val2": "-27.30",
          "chgp": "-96.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-50.60",
          "val2": "-27.30",
          "chgp": "-85.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'23 - YoYstock-summary
Sep'23
Sep'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-16.40
-15.80
-3.80%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-13.50
-14.70
8.16%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2023 is 8.16% vs -98.65% in Sep 2022

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-53.60
-27.30
-96.34%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-50.60
-27.30
-85.35%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -85.35% vs -127.50% in Dec 2021

All Annual Resultsstock-summary
stock-summaryCompany CV
About Theseus Pharmaceuticals, Inc. stock-summary
stock-summary
Theseus Pharmaceuticals, Inc.
Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."